MD2035G2 - Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali - Google Patents

Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali Download PDF

Info

Publication number
MD2035G2
MD2035G2 MDA20010172A MD20010172A MD2035G2 MD 2035 G2 MD2035 G2 MD 2035G2 MD A20010172 A MDA20010172 A MD A20010172A MD 20010172 A MD20010172 A MD 20010172A MD 2035 G2 MD2035 G2 MD 2035G2
Authority
MD
Moldova
Prior art keywords
decreasing
natural
contraction induced
vascular contraction
vasoconstrictor agents
Prior art date
Application number
MDA20010172A
Other languages
English (en)
Russian (ru)
Other versions
MD2035F1 (ro
Inventor
Михаил ПОПОВИЧ
Валериу КОБЕЦ
Виктория ИВАНОВ
Ион ПОПОВИЧ
Олег КАЛЕНИЧ
Михай ТОДИРАШ
Валентин ГУДУМАК
Валериу РУДИК
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MDA20010172A priority Critical patent/MD2035G2/ro
Publication of MD2035F1 publication Critical patent/MD2035F1/ro
Publication of MD2035G2 publication Critical patent/MD2035G2/ro

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Invenţia se referă la medicină, în special la cardiologie.Esenţa invenţiei constă în aceea că pentru micşorarea contracţiei vasculare induse de agenţii vasoconstrictori naturali, zilnic se administrează extract de spirulină în microdoze de 10…12 mg, per os, sau 41…49 µg/kilocorp intravenos, atingând astfel concentraţia serică eficientă de 55…65 µg%.
MDA20010172A 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali MD2035G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Publications (2)

Publication Number Publication Date
MD2035F1 MD2035F1 (ro) 2002-11-30
MD2035G2 true MD2035G2 (ro) 2003-05-31

Family

ID=19739861

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010172A MD2035G2 (ro) 2001-05-28 2001-05-28 Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali

Country Status (1)

Country Link
MD (1) MD2035G2 (ro)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Franz H. Meesseril, Current Cardiovascular Drug Therapy, New Orlean, 2000, p. 1400. *
Gavras H. Angiotensin-converting enzyme inhibition and the cardiovascular system, Hypertension. Nr. 23, 1994, p. 813…818. *
Thomas W. Smith,.Cardiovascular Therapeuticas, Brigham, 1996, p. 715. *
Чазов Е. И. Болезни органов кровообращения. Москва, 1997, с.831. *

Also Published As

Publication number Publication date
MD2035F1 (ro) 2002-11-30

Similar Documents

Publication Publication Date Title
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
MA28009A1 (fr) Derives de pyridazine et utilisation de ceux-ci en tant qu'agents therapeutiques
EA200100872A1 (ru) Композиция валдекоксиба
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
BG101118A (en) Therapeutical compounds
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
WO2001054681A8 (en) Composition for treatment of stress
UA98462C2 (ru) Способы лечения аутоиммунных заболеваний с использованием слитой молекулы taci-ig
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
DE69928806D1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
PL368686A1 (en) Novel aminobenzoephenones
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
MD2035G2 (ro) Metodă de micşorare a contracţiei vasculare induse de agenţii vasoconstrictori naturali
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
WO2000071109A3 (en) Pharmaceutical compositions comprising s-(+) -desmethylselegiline for the treatment of withdrawal
BG105434A (bg) Сертралинов орален концентрат
GEP20043377B (en) Pharmaceutical Complex
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására
MA49754B1 (fr) Méthodes de traitement de symptômes de gastroparésie au moyen de velusetrag
MD1854F1 (ro) Metoda de tratament in insuficienta cardiaca congestiva
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees